Isbn: 9783330318892 - antibiogram & detection of esbl & mbl in gram-negative bacteria (6 Ergebnisse)

ISBN
Mit der Detailsuche verfeinern

Optimieren Sie Ihre Suche

  • Bücher (6)

  • Neu (6)

bis

Benutzerdefinierte Preisspanne (EUR)

bis

    • Sprache: Englisch

      Verlag: LAP LAMBERT Academic Publishing, 2017

      3330318899 / 9783330318892

      • Softcover

      Anbieter: preigu, Osnabrück, Deutschlandpreigu

      Verkäufer/-in mit 5 Sternen
      Verkäufer/-in kontaktieren

      Zustand: Neu

      EUR 55,65

      EUR 70,00 Versand 
      Versand von Deutschland nach USA

      Anzahl: 5 verfügbar

      Taschenbuch. Zustand: Neu. Antibiogram & Detection of ESBL & MBL in Gram-Negative Bacteria | Chika Ejikeugwu (u. a.) | Taschenbuch | 164 S. | Englisch | 2017 | LAP LAMBERT Academic Publishing | EAN 9783330318892 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu.

    • Sprache: Englisch

      Verlag: LAP LAMBERT Academic Publishing, 2017

      3330318899 / 9783330318892

      • Softcover

      Anbieter: Revaluation Books, Exeter, Vereinigtes KönigreichRevaluation Books

      Verkäufer/-in mit 5 Sternen
      Verkäufer/-in kontaktieren

      Zustand: Neu

      EUR 131,87

      EUR 11,68 Versand 
      Versand von Vereinigtes Königreich nach USA

      Anzahl: 1 verfügbar

      Paperback. Zustand: Brand New. 164 pages. 8.66x5.91x0.37 inches. In Stock.

    • Sprache: Englisch

      Verlag: LAP LAMBERT Academic Publishing, 2017

      3330318899 / 9783330318892

      • Softcover

      Anbieter: Mispah books, Redhill, SURRE, Vereinigtes KönigreichMispah books

      Verkäufer/-in mit 4 Sternen
      Verkäufer/-in kontaktieren

      Zustand: Neu

      EUR 271,80

      EUR 29,19 Versand 
      Versand von Vereinigtes Königreich nach USA

      Anzahl: 1 verfügbar

      paperback. Zustand: New. NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

    • Sprache: Englisch

      Verlag: LAP LAMBERT Academic Publishing Aug 2017, 2017

      3330318899 / 9783330318892

      • Softcover
      • Print-on-Demand

      Anbieter: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, DeutschlandBuchWeltWeit Ludwig Meier e.K.

      Verkäufer/-in mit 5 Sternen
      Verkäufer/-in kontaktieren

      Zustand: Neu

      EUR 64,90

      EUR 23,00 Versand 
      Versand von Deutschland nach USA

      Anzahl: 2 verfügbar

      Taschenbuch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The emergence of new beta-lactamases such as extended spectrum beta-lactamase (ESBL) and metallo beta-lactamase (MBL) is an important mechanism by which pathogenic bacteria develop resistance to beta-lactams. This is of global concern as they are known to make the treatment of bacterial related infections difficult. The objective of this research was to determine phenotypically the occurrence of ESBL and MBL-producing Gram-negative bacteria from clinical isolates. ESBL was detected in 7.5 % Escherichia coli and 33.3 % Klebsiella pneumoniae. None of the P. aeruginosa isolates in our study showed ESBL production by the double disk synergy test (DDST) method. Disk potentiation test detected MBL in 12.5 % E. coli, 15.4 % Klebsiella pneumoniae and 10 % P. aeruginosa isolates while modified Hodges test also detected MBL in 12.5 % Escherichia coli, 7.7 % Klebsiella pneumoniae and 15 % Pseudomonas aeruginosa isolates. Our study reveals that Gram-negative bacteria of clinical origin produce ESBL and MBL. ESBL and MBL detection is crucial as this will help physicians to prescribe the proper therapy for affected patients. Rational use of antibiotics is vital to control resistant microbes. 164 pp. Englisch.

    • Sprache: Englisch

      Verlag: LAP LAMBERT Academic Publishing Aug 2017, 2017

      3330318899 / 9783330318892

      • Softcover
      • Print-on-Demand

      Anbieter: buchversandmimpf2000, Emtmannsberg, BAYE, Deutschlandbuchversandmimpf2000

      Verkäufer/-in mit 5 Sternen
      Verkäufer/-in kontaktieren

      Zustand: Neu

      EUR 64,90

      EUR 60,00 Versand 
      Versand von Deutschland nach USA

      Anzahl: 1 verfügbar

      Taschenbuch. Zustand: Neu. This item is printed on demand - Print on Demand Titel. Neuware -The emergence of new beta-lactamases such as extended spectrum ß-lactamase (ESBL) and metallo ß-lactamase (MBL) is an important mechanism by which pathogenic bacteria develop resistance to beta-lactams. This is of global concern as they are known to make the treatment of bacterial related infections difficult. The objective of this research was to determine phenotypically the occurrence of ESBL and MBL-producing Gram-negative bacteria from clinical isolates. ESBL was detected in 7.5 % Escherichia coli and 33.3 % Klebsiella pneumoniae. None of the P. aeruginosa isolates in our study showed ESBL production by the double disk synergy test (DDST) method. Disk potentiation test detected MBL in 12.5 % E. coli, 15.4 % Klebsiella pneumoniae and 10 % P. aeruginosa isolates while modified Hodges test also detected MBL in 12.5 % Escherichia coli, 7.7 % Klebsiella pneumoniae and 15 % Pseudomonas aeruginosa isolates. Our study reveals that Gram-negative bacteria of clinical origin produce ESBL and MBL. ESBL and MBL detection is crucial as this will help physicians to prescribe the proper therapy for affected patients. Rational use of antibiotics is vital to control resistant microbes.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 164 pp. Englisch.

    • Sprache: Englisch

      Verlag: LAP LAMBERT Academic Publishing, 2017

      3330318899 / 9783330318892

      • Softcover
      • Print-on-Demand

      Anbieter: AHA-BUCH GmbH, Einbeck, DeutschlandAHA-BUCH GmbH

      Verkäufer/-in mit 5 Sternen
      Verkäufer/-in kontaktieren

      Zustand: Neu

      EUR 64,90

      EUR 61,31 Versand 
      Versand von Deutschland nach USA

      Anzahl: 1 verfügbar

      Taschenbuch. Zustand: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - The emergence of new beta-lactamases such as extended spectrum beta-lactamase (ESBL) and metallo beta-lactamase (MBL) is an important mechanism by which pathogenic bacteria develop resistance to beta-lactams. This is of global concern as they are known to make the treatment of bacterial related infections difficult. The objective of this research was to determine phenotypically the occurrence of ESBL and MBL-producing Gram-negative bacteria from clinical isolates. ESBL was detected in 7.5 % Escherichia coli and 33.3 % Klebsiella pneumoniae. None of the P. aeruginosa isolates in our study showed ESBL production by the double disk synergy test (DDST) method. Disk potentiation test detected MBL in 12.5 % E. coli, 15.4 % Klebsiella pneumoniae and 10 % P. aeruginosa isolates while modified Hodges test also detected MBL in 12.5 % Escherichia coli, 7.7 % Klebsiella pneumoniae and 15 % Pseudomonas aeruginosa isolates. Our study reveals that Gram-negative bacteria of clinical origin produce ESBL and MBL. ESBL and MBL detection is crucial as this will help physicians to prescribe the proper therapy for affected patients. Rational use of antibiotics is vital to control resistant microbes.